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Abstract 
Background Women with a family history of breast cancer may 
be at higher risk for breast cancer, but few previous studies 
evaluating diet and breast cancer have focused on such women. 
The objective of the present study was to determine whether 
diet, a modifiable risk factor, is related to breast density among 
women at high genetic risk for breast cancer. 
Methods Women with at least one first-degree or second-
degree relative with breast cancer or ovarian cancer 
participating in the Fox Chase Cancer Center Family Risk 
Assessment Program completed health history and food 
frequency questionnaires and received standard screening 
mammograms. Cranial–caudal mammographic images were 
classified into the four Breast Imaging Reporting and Data 
System categories ranging from 'entirely fatty' to 'extremely 
dense'. Logistic regression analysis using proportional odds 
models for polychotomous outcomes provided estimates of 
odds ratios for having a higher category versus a lower category 
of breast density. 
Results Among 157 high-risk women, breast density was 
inversely associated with vitamin D intake (odds ratio for third 
tertile versus first tertile, 0.5; 95% confidence interval, 0.2–1.0). 
In contrast, intakes above the median level for protein (odds 
ratio, 3.0; 95% confidence interval, 1.3–6.9) and above the 
median level for animal protein (odds ratio, 4.3; 95% confidence 
interval, 1.8–10.3) were associated with higher breast density, 
but only among women whose family history did not reflect a 
known familial cancer syndrome or a breast cancer 
predisposition gene. 
Conclusion For women with a strong family history that was not 
associated with known cancer syndromes, dietary factors may 
be associated with breast density, a strong predictor of breast 
cancer risk. Since women with strong family history are often 
very motivated to change their lifestyle habits, further studies are 
needed to confirm whether changes in diet will change the 
breast density and the subsequent onset of breast cancer in 
these women. 
Introduction 
Women with a family history of breast cancer may be at higher 
genetic risk for breast cancer because of either recognized 
deleterious mutations or as yet unidentified low-penetrance 
alleles. Such women are likely to be especially motivated to 
modify their lifestyle to reduce their risk for breast cancer. Diet 
modification is one possible strategy, but few previous studies 
evaluating diet and breast cancer have focused on women at 
high genetic risk [1,2]. 
Breast density, the percentage of total breast area with a mam­
mographically dense appearance, is an informative marker for 
breast cancer risk because of its strong association with 
breast cancer [3-5]. Breast density has been shown to predict 
risk among women with a genetic predisposition for breast 
cancer [6], including women carrying BRCA1 or BRCA2 
mutations [7]. Among the few studies on diet and breast den­
sity [8-16], only one specifically included women with a family 
history of the disease [17]. The objective of the present study 
was to evaluate associations between dietary intake and 
breast density among women at potentially high genetic risk 
for breast cancer. We focused on dietary factors associated 
with breast density in previous studies conducted among 
average-risk samples [8-10,12-15,18], as well as on sus­
pected risk factors or protective factors for breast cancer [19]   
FRAP = Family Risk Assessment Program. 
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Materials and methods 
Study population 
The study sample was drawn from 1,313 women enrolled in 
the Family Risk Assessment Program (FRAP) at Fox Chase 
Cancer Center in Philadelphia from September 1991 to April 
2001. The FRAP was initiated in 1991 to offer education and 
preventive interventions, and to serve as a research base for 
studying gene–environment interactions in breast cancer and 
ovarian cancer. Women are eligible for the FRAP if they have 
at least one first-degree or second-degree relative with breast 
cancer or ovarian cancer. Recruitment strategies include refer­
rals from breast cancer patients or ovarian cancer patients at 
Fox Chase Cancer Center, radio and newspaper advertise­
ments, and physician referrals and self-referrals. 
FRAP participants were eligible for the breast density study if 
they were at least 40 years old. Exclusion criteria included a 
history of breast augmentation or reduction, a history of pro­
phylactic mastectomy, a history of cancer except non-
melanoma skin cancer, a current or planned pregnancy, 
current breastfeeding, a weight change of at least 20 lb during 
the past year, a substantial change in diet over the past year, 
or no mammogram planned within the study timeframe. Of 510 
potentially eligible women invited to participate, 177 women 
agreed, 153 women declined, 125 women could not be con­
tacted, and 55 women were subsequently found to be ineligi­
ble. An additional 13 women were excluded – because their 
questionnaires were inadequately completed (n = 7), because 
their mammograms could not be obtained (n = 5), or because 
they reported an energy intake >3,500 kcal/day (n = 1) – leav­
ing 164 for inclusion in analyses. A comparison of the women 
included in the analysis with remaining women in the partici­
pant pool showed no significant differences in age, ethnicity, 
level of education, body mass index, dietary intake, or smoking 
status, but participants were more likely than nonparticipants 
to have a first-degree relative with breast cancer (74% versus 
61%, P = 0.008). 
Data collection 
Upon enrollment into the FRAP, women completed a health 
history questionnaire for baseline information on sociodemo­
graphic characteristics, family history of cancer, and reproduc­
tive factors, including age at menarche. In 1996, detailed 
questions on pregnancy history were added to the baseline 
questionnaire. Each year after their baseline, the FRAP partic­
ipants were also asked to complete a follow-up questionnaire 
for updated information on pregnancies and new occurrences 
of cancer in the family. 
Pedigrees provided at baseline and updated annually were 
reviewed by a team of genetic counselors, and were classified 
as reflecting one of four categories: (1) sporadic, indicated by 
a single occurrence of cancer diagnosed at any age occurring 
on one side of the family only; (2) familial, reflecting a pattern 
of cancers seen in at least one generation but not fitting a 
known cancer family syndrome; (3) putative hereditary, fitting 
a hereditary pattern of cancer inheritance or known cancer 
family syndrome not yet confirmed by genetic testing; or (4) 
confirmed hereditary, representing inheritance of a cancer pre­
disposition gene confirmed through genetic testing performed 
on the proband or on a relative. Women in the putative and 
confirmed hereditary categories (categories (3) and (4)) were 
grouped together in analyses to reflect the presence of a can­
cer family syndrome whether based on pedigree analysis or 
genetic testing. Such pedigrees primarily reflected the pres­
ence of a BRCA1 or BRCA2 mutation but also included other 
cancer family syndromes such as Li–Fraumeni syndrome or 
Cowden's disease. 
All FRAP participants were also asked to complete the Har­
vard Diet Assessment Form [20] for information on intake fre­
quencies over the previous year of 126 food items and of 
vitamin and mineral supplement use. The Diet Assessment 
Form was found to be reasonably valid in a sociodemographi­
cally similar sample of women [21]. 
Participants in the breast density study received a standard 
screening mammogram at Fox Chase Cancer Center, were 
measured for weight and height, completed another Diet 
Assessment Form for their dietary intake for the year previous 
to the study mammogram, and completed an additional ques­
tionnaire for updated information on smoking habits, physical 
activity, and reproductive factors including pregnancies, 
breastfeeding, use of hormonal contraceptives or hormone 
replacement medicine, age at first live birth, and menopausal 
status. Menopausal status was determined based on whether 
the participant reported having had a menstrual period within 
the last year. The study protocol was approved by the Institu­
tional Review Board of the Fox Chase Cancer Center (IRB 
protocol number 00-803), and all participants gave their writ­
ten informed consent to participate in the study. 
Breast density assessment 
All participants received a standard screening mammogram. 
For premenopausal women, all efforts were made to schedule 
mammograms during the follicular phase of each woman's 
menstrual cycle, when breast tissue is less radiographically 
dense [22]. Breast density was assessed by the study radiol­
ogist (KAE), who was blinded to the identity and other per­
sonal characteristics of study subjects, using the Breast 
Imaging Reporting and Data System: 1 = entirely fatty, 2 = 
scattered fibroglandular tissue, 3 = heterogeneously dense, 
and 4 = extremely dense [23]. 
Results presented below are based on radiological classifica­
tions for the cranial–caudal view of a randomly selected side. 
Consistent with previous work [24], however, left-side and 
right-side assessments were highly correlated (r = 0.97) in the 
172 women with mammographic data, and assessments 
between left and right sides agreed in all but 10 (6%) women.  Page 2 of 9 
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In reproducibility assessments conducted in a randomly 
selected set of 52 images, we calculated a kappa statistic of 
0.97 for the left-side images and 0.89 for the right-side 
images. 
Data analysis 
We used logistic regression analysis for polychotomous out­
comes using proportional odds models [25] to estimate the 
odds ratios. All log odds can be interpreted as the odds for a 
woman having a higher category versus a lower category for 
breast density [25]. Dietary factors of interest were calories, 
total fat and saturated fat, cholesterol, protein, animal protein, 
carbohydrates, dietary fiber, carotene, folate, calcium, vitamin 
D, and vitamin E, as well as foods and food groups including 
meats, fruits and vegetables, tofu, and alcoholic beverages. 
Nutrient values included both dietary and supplemental 
sources and were energy-adjusted using the residual method 
[26]. The odds ratios were estimated for upper tertiles versus 
lower tertiles of intake; but for infrequently consumed items 
such as tofu, estimates were for consumption versus noncon­
sumption. Variables evaluated as potential confounders 
included age, body mass index, level of education (college 
graduate or not), age at menarche, number of live births, age 
at first live birth, ever breastfed, menopausal status, ever use 
of hormonal contraceptives, ever use of hormone replacement 
therapy, physical activity (hours per week), smoking status 
(never, former, current), family history category (sporadic, 
familial, hereditary), and energy intake. Too few women 
reported current use of either hormonal contraceptives or hor­
mone replacement therapy to examine their associations with 
breast density separately from previous use. 
Final multivariate models included 157 women with complete 
covariate data and adjusted for age, body mass index, caloric 
intake, age at menarche, menopausal status, history of hor­
mone replacement therapy use, and family history category. 
Results were not materially different when we excluded six 
women who reported current use of either raloxifene or 
tamoxifen. Because detailed questions on pregnancy history 
were not included in the baseline questionnaire until 1996, a 
large number of women had incomplete data on number of live 
births and age at first live birth. We therefore ran separate 
models to examine potential confounding by these factors in 
the subset of women with complete data for these variables. 
The P values for a linear trend were obtained for each dietary 
variable using an ordinal variable representing the scaled 
median value for each tertile. We examined effect modification 
by menopausal status using stratified models with each dietary 
variable dichotomized at the median. The P values for interac­
tion were obtained from a model including all women, with a 
dietary variable x menopausal status interaction term. Because 
we observed no significant differences in effect estimates by 
menopausal status, results presented are for premenopausal 
women and postmenopausal women combined. We used a 
similar strategy to examine effect modification by family history 
category, comparing women with a hereditary family history of 
cancer with women without such a family history. We com­
bined women with sporadic breast cancer family histories and 
women with familial breast cancer family histories because 
there were too few women (n = 32) with only a family history 
of sporadic breast cancer. In contrast to women with a hered­
itary family history of cancer based on pedigrees or genetic 
testing representing a stronger genetic predisposition to 
breast cancer, women with sporadic breast cancer family his­
tories and familial breast cancer family histories may represent 
women with lower-penetrance susceptibility genes that have 
not yet been identified, but that still places them at higher 
genetic risk. 
Results 
The 157 women in the analysis had a mean ± standard devia­
tion age of 50 ± 8 years; 96% were white, and 73% had at 
least a college degree. Among the mammographic images 
included in the analyses, 12.7% (n = 20) were classified as 
entirely fatty, 28.0% (n = 44) as having scattered fibroglandu­
lar tissue, 34.4% (n = 54) as heterogeneously dense, and 
24.8% (n = 39) as extremely dense. Having denser breasts 
was associated with younger age, lower body mass index, 
older age at menarche, smaller number of live births, older age 
at first live birth, and a history of having used hormone replace­
ment therapy (Table 1). Menopausal status was inversely 
associated with breast density, but not significantly after 
adjustment for age. Level of education, current smoking, and a 
hereditary family history of breast cancer showed nonsignifi­
cant positive associations with breast density. We observed 
no associations with breast density for breastfeeding, history 
of oral contraceptive use, or physical activity. 
Breast density was significantly inversely associated with 
intake of vitamin D (Table 2); women in the highest tertile of 
vitamin D intake were one-half as likely to have higher breast 
density as women in the lowest tertile (odds ratio, 0.5; 95% 
confidence interval, 0.2–1.0). We also observed a suggestive 
but nonsignificant inverse association for folate (odds ratio, 
0.5 for highest tertile versus lowest tertile; 95% confidence 
interval, 0.2–1.1; trend P = 0.09). Breast density was not 
associated with any other nutrients of interest (Table 2) or with 
any foods of interest (meats, fruits and vegetables, tofu, alco­
holic beverages – results not shown) among all participants 
combined. 
In stratified analyses, we found evidence for effect modifica­
tion by family history category (Table 3). Whereas protein 
intake and animal protein intake were not significantly associ­
ated with breast density among women with a hereditary pat­
tern of family history of breast cancer, these nutrients were 
positively associated with breast density among women with 
sporadic or other familial histories. The odds ratios for women 
with intake above the median were 3.0 (95% confidence inter-Page 3 of 9 
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Table 1 
Characteristics of women by breast density category, and odds ratios for association with denser breast category (n = 157) 
Characteristic Entirely fatty (n = 20) Heterogeneously Scattered Extremely dense Age-adjusted odds ratio 
dense (n = 44) fibroglandular tissue (n = 39) (95% confidence interval)a 
(n = 54) 
Age (years) 54.1 ± 1.0 53.9 ± 0.9 48.7 ± 0.6 47.4 ± 0.7 0.4 (0.3–0.6)b
 
College graduate (%)c 55 72 72 84 1.5 (0.8–3.0)
 
Body mass index (kg/m2) 33.3 ± 7.1 28.3 ± 6.1 24.8 ± 4.4 23.8 ± 3.0 0.8 (0.8–0.9)
 
Age at menarche (years) 12.4 ± 1.3 12.3 ± 1.3 12.5 ± 1.4 13.1 ± 1.8 1.3 (1.1–1.6)
 
Number of live birthsc 3.1 ± 1.4 2.5 ± 1.6 2.6 ± 0.9 1.9 ± 1.0 0.8 (0.6–1.0)
 
Age at first birth (years)c 23.7 ± 5.9 25.6 ± 4.1 27.4 ± 5.8 29.5 ± 5.1 1.1 (1.0–1.2)
 
Ever breastfedc 30 72 63 75 1.0 (0.4–2.7)
 
Postmenopausal 65 66 33 28 0.5 (0.3–1.2)
 
Ever used hormonal 45 41 63 37 0.8 (0.5–1.4)
 
contraceptives
 
Ever used hormone 85 45 56 36 0.4 (0.2–1.0)
 
replacement medicined
 
Weekly physical activity 2.9 ± 2.9 3.6 ± 3.0 3.5 ± 2.9 2.9 ± 2.5 1.0 (0.8–1.1)
 
(hours)
 
Smoking status
 
� Never smoked 50 49 57 61 1.0 
� Former smoker 45 49 39 26 0.6 (0.3–1.1) 
� Current smoker 5 2 4 13 2.0 (0.5–7.6) 
Family history of breast cancer 
� Negative or sporadic 15 30 22 10 1.0 
� Familial 35 45 33 33 1.3 (0.6–2.9) 
� Hereditary 50 25 44 56 1.8 (0.8–4.0) 
Characteristics data presented as the mean ± standard deviation or as the percentage. aOdds ratios adjusted for age except for the age variable. 
bOdds ratio for 10-year age increment. c Because of missing responses, analyses included only 155 women for education level, 125 women for 
number of live births, 120 parous women for age at first live birth, and 74 parous women for breastfeeding. dAnalysis conducted among 70
postmenopausal women. 
val, 1.3–6.9) and 4.3 (95% confidence interval, 1.8–10.3) for 
protein and animal protein, respectively. These results were 
not meaningfully different when we controlled for number of 
live births and age at first live birth in the 120 women with com­
plete data (results not shown). 
Discussion 
In this broad exploration of dietary factors, we found that only 
vitamin D intake was inversely associated with breast density 
in a sample of women enrolled in a high-risk program for breast 
cancer. Protein and animal protein were positively associated 
with breast density, but only among women not classified as 
having the hereditary familial cancer patterns. 
Our results are consistent with recent work showing an 
inverse association between vitamin D and breast density 
[14,18], as well as studies suggesting a protective effect of 
vitamin D against breast cancer [27]. A previous study 
observed an inverse association of vitamin D with breast den­
sity only among premenopausal women [18], and primarily 
among premenopausal women with higher levels of insulin-like 
growth factor 1 or of insulin-like growth factor binding protein 
3 [28]. In the present study, we saw no difference in effect by 
menopausal status. Vitamin D may lower breast density 
through the antiproliferative and proapoptic effects of its bio­
logically active form, 1,25-dihydroxyvitamin D, or through mod­
ulation of the immune system [27,29]. Notably, most tissues 
and cells, including those in the breast, have vitamin D recep­
tors and are also able to metabolize circulating 25-hydroxyvita­
min D to 1,25-dihydroxyvitamin D, allowing for local, cellular 
effects in the breast tissue [29]. 
Whether the inverse association we observed is truly attribut­
able to a protective effect of dietary vitamin D, however, 
remains unclear. We did not assess sunlight exposure, 
another important determinant of vitamin D status, nor did we 
have serum samples available to assess the relationship of 
breast density either with 25-hydroxyvitamin D as an indicator  Page 4 of 9 
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Table 2 
Adjusted odds ratiosa and 95% confidence intervals by tertile of nutrient intake (n = 157) 
Nutrient Tertile 1 Tertile 2 Tertile 3 Trend P valueb 
Energy (kcal) 
� Median per day 1,357 1,807 2,444 
� Odds ratio (95% confidence interval) 1.0 1.6 (0.7–3.3) 0.9 (0.4–2.0) 0.79 
Total fat (g) 
� Median per day 55.5 60.8 73.1 
� Odds ratio (95% confidence interval) 1.0 1.9 (0.9–4.2) 1.5 (0.7–3.1) 0.33 
Saturated fat (g) 
� Median per day 18.7 22.4 27.2 
� Odds ratio (95% confidence interval) 1.0 0.9 (0.4–1.9) 0.9 (0.4–1.9) 0.70 
Cholesterol (mg) 
� Median per day 200 221 305 
� Odds ratio (95% confidence interval) 1.0 1.6 (0.7–3.6) 1.2 (0.5–2.7) 0.72 
Protein (g) 
� Median per day 76.0 76.0 93.4 
� Odds ratio (95% confidence interval) 1.0 1.0 (0.5–2.2) 0.9 (0.4–2.0) 0.87 
Animal protein (g) 
� Median per day 49.0 51.0 68.4 
� Odds ratio (95% confidence interval) 1.0 1.0 (0.5–2.3) 1.1 (0.5–2.3) 0.87 
Carbohydrates (g) 
� Median per day 174.0 228.5 304.6 
� Odds ratio (95% confidence interval) 1.0 0.7 (0.3–1.5) 0.9 (0.4–1.9) 0.79 
Fiber (mg) 
� Median per day 12.4 18.5 27.2 
� Odds ratio (95% confidence interval) 1.0 0.5 (0.2–1.1) 0.7 (0.3–1.5) 0.57 
Carotene (IU) 
� Median per day 4,969 8,621 17,714 
� Odds ratio (95% confidence interval) 1.0 0.5 (0.3–1.2) 0.7 (0.3–1.5) 0.51 
Folate (mcg) 
� Median per day 344 650 943 
� Odds ratio (95% confidence interval) 1.0 0.7 (0.3–1.5) 0.5 (0.2–1.1) 0.09 
Calcium (mg) 
� Median per day 766 1,271 1,871 
� Odds ratio (95% confidence interval) 1.0 1.4 (0.6–3.0) 1.0 (0.5–2.1) 0.83 
Vitamin D (IU) 
� Median per day 164 463 737 
� Odds ratio (95% confidence interval) 1.0 0.7 (0.3–1.5) 0.5 (0.2–1.0) 0.05 
Vitamin E (mg) 
� Median per day 6.8 40.9 436.4 
� Odds ratio (95% confidence interval) 1.0 0.4 (0.2–1.0) 0.6 (0.3–1.2) 0.37 
aModels adjusted for age, body mass index, caloric intake, age at menarche, menopausal status, hormone therapy use, and family history category. 
bP value for trend obtained by including in the model a variable representing the median value for each tertile. Page 5 of 9 
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Table 3 
Adjusted odds ratiosa and 95% confidence intervals for dichotomized dietary intakeb by family history category 
Sporadic or familial family history (n = 90) Hereditary family history (n = 67) 
Median (g) Odds ratio (95% Median (g) Odds ratio (95% 
confidence interval) confidence interval) 
Protein 
� Low 76.2 1.0 77.6 1.0 
� High 93.5 3.0 (1.3–6.9) 91.0 0.4 (0.1–1.4) 
� P value for interactionc <0.001 
Animal protein 
� Low 51.6 1.0 49.0 1.0 
� High 66.4 4.3 (1.8–10.3) 69.6 0.5 (0.1–1.5) 
� P value for interaction <0.001 
aModels adjusted for age, body mass index, caloric intake, age at menarche, menopausal status, hormone therapy use, and vitamin D intake. 
bDichotomized at median value. cP value for interaction was obtained by including in the model of a dichotomized dietary variable x family history 
category interaction term. 
of vitamin D status or with 1,25-dihydroxyvitamin D. Of two 
previous studies that examined 25-hydroxyvitamin D in relation 
to breast density, one study saw a protective effect [30] while 
the other study did not [30]. In additional analyses we explored 
whether breast density might be more strongly associated 
with major dietary sources of vitamin D, such as dairy or fish, 
but we observed no clear associations (results not shown). 
Our results are also consistent with previous studies that 
found positive associations of breast density with protein or 
meat intake [11,12,31]. Animal protein intake may increase 
breast density by increasing circulating levels of insulin-like 
growth factor-1 [32,33], which has been linked to higher 
breast density [34] and higher breast cancer risk [35-37] 
among premenopausal women. In the present study, the asso­
ciations for protein and animal protein were limited to women 
without a hereditary family history of breast cancer. Classifica­
tion of a hereditary family history of breast cancer in our sam­
ple primarily represented the presence of a BRCA1 mutation 
or a BRCA2 mutation. While this effect modification may be a 
chance finding, it may also suggest that, in such women, the 
same genetic factors that predispose to higher breast cancer 
risk increase the risk for dense breasts as well [38], and that 
genetic effects can overwhelm the effects of reduced dietary 
protein. For example, if BRCA1 exerts downstream effects on 
transcription, expression, or circulating levels of members of 
the insulin-like growth factor system as suggested by recent 
work [39-41], then breast tissue may be denser among 
BRCA1 mutation carriers [38] regardless of their level of pro­
tein intake. 
Other dietary factors may affect breast density by affecting 
estrogen levels or by directly affecting breast tissue morphol­
ogy [8,10,14] – but only limited, indirect evidence exists to 
support these mechanisms, and previous study findings with 
respect to other dietary factors have been inconsistent. In 
cross-sectional analyses, breast density has been both posi­
tively associated [8,9,11,31] and inversely associated [13,17] 
with total and saturated fat intake. Findings for soy and isofla­
vones have been similarly mixed [13,15,16,42,43]. Among 
other nutrients, higher breast density has been related to alco­
hol intake [17,44,45] and inversely related to carotenoid, fiber, 
and calcium [8,9,14,18,45,46]. 
Previous studies have observed a protective effect of folate 
against breast cancer [47], possibly because of its role in DNA 
methylation, synthesis, and repair [48], although breast den­
sity studies have not supported this [17,45]. In our sample we 
observed only a suggestive, nonsignificant inverse associa­
tion. A protective effect of folate may be more pronounced 
among women with high alcohol intake [47], and alcohol 
intake in our sample was generally low (median 1.1 g/day alco­
hol). While too few women reported even moderate alcohol 
intake to examine folate in this group separately, when we 
excluded nine women with alcohol intake >15 g/day the 
inverse association for folate was slightly attenuated (trend P 
= 0.27). 
Difficulties in assessing breast density may contribute to the 
inconsistent results of studies on diet and breast density. Most 
studies, including the current analysis, defined breast density 
in categories of percentage density. While the method is more 
subjective than a computer-assisted method [49], the Breast 
Imaging Reporting and Data System categories are neverthe­
less a strong predictor of breast cancer risk [50]. Some work­
ers have suggested that absolute size of the area of density is  Page 6 of 9 
(page number not for citation purposes) 
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the more relevant measure [51], but only four previous studies 
presented results for dense area size [11,15,16,42] – three of 
which focused specifically on soy or isoflavones [15,16,42]. 
The relevant time period of exposure is also unclear. Women 
randomized to a low-fat, high-carbohydrate diet for 2 years as 
part of the Canadian Diet and Breast Cancer Prevention Study 
Group experienced a greater decrease in area of breast den­
sity relative to a nonintervention group [10,11], suggesting 
that recent, relatively short-term dietary exposures can affect 
breast density and possibly breast cancer risk, at least in pre­
menopausal women or perimenopausal women. In contrast, a 
2-year soy intervention had no effect on breast density change 
over time, although soy consumption in early life and adult­
hood did appear to influence density change [16]. 
A limitation of the present study is its relatively small sample 
size, which limited our ability to detect significant associations 
and effect modification by menopausal status. Our sample is 
unique, however, in that all women had a family history of 
breast cancer. Moreover, over 40% of them had a family his­
tory indicating the presence of a high-penetrance cancer pre­
disposition gene, or had been tested to confirm it. 
Examining only the recent diet may additionally have limited 
our ability to evaluate the role of dietary intake in relation to 
breast density. Findings were not different when we used the 
average value of dietary intake reported at enrollment into the 
FRAP and that reported for the current breast density study, 
with a median time interval between the two administrations of 
4.5 years, but no other dietary information was available to 
assess effects of longer-term dietary intake on breast density. 
Data were incomplete for the number of live births and for age 
at first live birth; but despite their significant associations with 
breast density, these two variables were not important con­
founders among the 120 women not missing this information. 
Our findings may be biased if a woman's knowledge of her 
breast density, or some characteristic related to her breast 
density, influenced her reporting of her dietary intake, or 
changed her intake so that her current report was not reflective 
of her long-term diet. For example, women with higher breast 
density may have been more likely to perceive themselves at 
higher risk for breast cancer and to modify their diets 
accordingly. We saw no differences, however, in either breast 
density or dietary intake by perception of risk for breast cancer 
reported at baseline (results not shown). 
Because of the large number of dietary factors explored in this 
analysis, our findings should be interpreted with caution, war­
rant further investigation into the etiologic mechanism and 
warrant confirmation in larger hypothesis-based and pathway-
based studies. 
Finally, our findings may be limited in their ability to be gener­
alized to other populations. Participants were drawn from par­
ticipants in a high-risk program, and, even among these 
women, those with a lesser family history of breast cancer 
were underrepresented in our sample. Nevertheless, the avail­
ability of detailed pedigrees is a significant strength of the 
study as it allowed us to classify women on the basis of their 
family history of breast cancer in more detail than has been 
conducted previously, and hence to distinguish women at the 
highest genetic risk for breast cancer. Our study offers sug­
gestive findings that should be confirmed in a larger sample 
representing a range of genetic and familial risk for breast can­
cer, in order to clarify the extent to which diet differences might 
be related to breast density, and whether effects differ by 
genetic susceptibility. Future studies might extend these find­
ings to see whether changes in dietary intake would be asso­
ciated with a change in breast density and a subsequent 
change in breast cancer risk. 
Conclusion 
In summary, in the present broad exploration of dietary factors 
in women enrolled in a high-risk program for breast cancer, we 
found that only vitamin D intake was inversely associated with 
breast density. Protein and animal protein intake were posi­
tively associated with breast density, but only among women 
without a hereditary family history of breast cancer. Our latter, 
tentative finding suggests that some dietary modification strat­
egies may be more effective in reducing breast density and 
hence breast cancer risk in women with a family history of 
breast cancer suggestive of lower-penetrance susceptibility 
genes, but this requires confirmation in a larger sample repre­
senting a range of genetic risks for breast cancer. 
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